M.S Pharmacy Studies at University of Washington 2026 Entry : Fee , Admission, documents, deadline etc

University of Washington (UW) Master of Science in Pharmacy is the Seattle-based, full-time, two-year Master of Science (MS) in Pharmaceutics. Applicants need a four-year biological-science degree, Calculus I and Grade Point Average (GPA) above 3.0, approximately 60% to 69% for Indian applicants. Autumn 2027 tuition is unpublished; 2026-27 tuition and fees were US$33,555 (INR 31.86 Lakhs), as a prior-cycle reference, and Autumn is the only intake.

The research-focused programme trains students in drug disposition, delivery, metabolism and pharmacokinetics through core science, laboratory work and a thesis. It best suits applicants seeking experimental pharmaceutical-science training who can commit substantial time beyond classes to assigned laboratory research.

• The current curriculum requires at least 57 credits, including 24 credits of master’s thesis research.
• Students select a thesis adviser at the beginning of their first Autumn quarter and start laboratory research immediately.
• The Classification of Instructional Programs code 51.2003 has a science, technology, engineering and mathematics designation, supporting an eligible extension after standard training.

Also Check: University of Washington Pharmacy Admission

University of Washington MS Pharmacy Fees and Living Costs 2027

Autumn 2027 tuition is not yet published on the live programme, tuition dashboard or international-expense page. Verify the target fee on the official fee page.

Prior-cycle planning reference: The figures below are UW’s published 2026-27 nonresident Tier I amounts for three academic quarters. They cannot be treated as the Autumn 2027 charge.

All INR conversions in the article use a conversion rate of US$ 1 = INR 94.94 as of 26 October 2026. Rates fluctuate daily, verify before applying.

Source: UW International Student Services estimated annual expenses for 2026-27.

The programme describes MS students as self-funded, so the calculated 2026-27 billed subtotal was US$35,166 (INR 33.39 Lakhs) before living costs. A teaching appointment may carry tuition support, but UW states that such positions are not guaranteed and require separate applications.

Cost of Living in Seattle for MS Pharmacy Students

UW’s 2026-27 Seattle graduate budget estimates nine-month living costs of US$28,113 (INR 26.69 Lakhs). Monthly figures below are calculated by dividing each university-published academic-year category by nine.

A prior-cycle planning illustration adds US$33,555 tuition and fees, US$28,113 living costs and US$1,611 insurance. The resulting nine-month total is US$63,279 (INR 60.08 Lakhs), excluding travel and any summer enrolment.

Read More: Cost of Living in the USA

ROI reality: The latest complete one-year reference reaches US$63,279 (INR 60.08 Lakhs), while the MS offers no guaranteed funding. Secure financing without assuming an assistantship or unchanged second-year tuition.

University of Washington MS Pharmacy Admission 2027

Admission requires a relevant four-year degree, quantitative preparation and GPA above 3.0. The programme accepts only Autumn entrants and currently lists no separate work-experience minimum.

Autumn 2027 Intake and Academic Eligibility

Autumn 2027 is the only published intake, with the international application open since 1 October 2026. The department evaluates preparation for a thesis programme rather than pharmacist licensure.

UW reports 40 to 80 MS applications and two to seven offers in different years. These ranges do not form one acceptance-rate cohort, but they show why focused laboratory choices and research evidence matter.

Selected MS applicants receive Zoom interviews beginning in early February. The committee makes collective decisions, so the department states that contacting an individual faculty member does not improve admission chances.

English Language Proficiency Requirements

The current Graduate School policy distinguishes a minimum score from a recommended score. Meeting only the minimum may lead to required Academic English Program courses after admission.

• Indian degree holders using the English-medium route must obtain official institutional documentation because India is not on UW’s documentation-exempt country list.
• Applicants taking TOEFL after 21 January 2026 should use UW’s published 1.0 to 6.0 scale and never self-convert an older score.
• Aim for the recommended English score because a minimum-only result can add compulsory English coursework and related charges.

Tip for Indian students: Clear the recommended English threshold and show calculus preparation before submission. Then use laboratory choices to prove readiness for immediate Autumn research rather than general professional-pharmacy interest.

University of Washington MS Pharmacy Application 2027

The Autumn 2027 application is open, and international applicants share the programme’s published dates. Priority submission matters because the department describes admission as rolling on its current programme page.

Application Timeline

The table lists every published Autumn 2027 stage for this MS. UW gives calendar dates but no target-programme cutoff timezone, so the application portal’s clock remains controlling.

Because no timezone is published for this programme, Indian applicants should finish each submission by 23:59 IST on the previous calendar date. That buffer avoids relying on an unverified Pacific-to-IST conversion.

Required Application Components

The graduate application fee is US$90 (INR 8,545) for each submitted programme. Departmental fee waivers are unavailable, while eligible Graduate School waiver requests must be filed at least seven calendar days before the deadline.

• Submit by 15 January because the programme identifies that date as its preferred rolling-review point.
• Explain one research problem for each chosen laboratory instead of repeating faculty biography language.
• Prepare concise examples of experimental setbacks and analysis decisions for a possible February interview.
• Use the official Pharmaceutics application listing to confirm live requirements before payment.

Check Out: MS Pharmacy Universities in the USA

Application tip: A 15 January submission preserves the department’s preferred review position and leaves time for score delivery. Build the file around three defensible laboratory matches, not generic pharmaceutical interest.

University of Washington MS Pharmacy Scholarships 2027

MS students are self-funded, and neither an assistantship nor an entry award is guaranteed. Department awards become relevant after enrolment because their eligibility requires active Pharmaceutics thesis research.

Current published awards: UW lists the opportunities below without assigning them to the Autumn 2027 cycle. Their published deadline is Spring quarter, but no calendar date appears on the live page.

The Kelly, Shen and Levy awards are useful for research development, but they do not materially close the published one-year cost gap. The two fellowship awards offer larger support, although UW publishes neither recipient counts nor Autumn 2027 application dates.

• Enter the programme with financing that covers the full published budget because all five awards are competitive after enrolment.
• Track Spring-quarter department announcements and prepare evidence of thesis progress, academic merit and the award’s specific use.
• Do not combine Ji-Ping Wang or Bradley funding with another training award because each published rule prohibits concurrent support.

Also Check: University of Washington Scholarships

Scholarship reality: The two largest department awards can cover one quarter’s tuition and stipend, but timing and selection remain unpublished. Treat every award as upside, not as an admission budget input.

University of Washington MS Pharmacy Salary 2027

UW publishes no MS Pharmaceutics cohort salary, offer rate or sector distribution. Its official programme material instead identifies pharmaceutical industry, academia and regulatory agencies as graduate destinations without measuring placement probability.

Career Evidence and Market Salary Benchmarks

The course builds evidence for research roles through drug-disposition science, clinical pharmacokinetics, biometry and at least 24 thesis credits. However, the salaries below are national occupation benchmarks, not UW graduate outcomes.

Source: US Bureau of Labor Statistics occupation data, published for May 2025.

These medians combine workers across experience levels and degrees, so they cannot estimate a new graduate’s offer. Independent research positions commonly require a doctorate, while the BLS identifies some entry roles for master’s holders.

ROI for an Indian Applicant

The academic value rests on laboratory access and a completed thesis, not a published placement pipeline. Its Classification of Instructional Programs (CIP) code 51.2003 carries a science, technology, engineering and mathematics (STEM) designation. Financially, the missing cohort outcome data makes a salary-based payback calculation unreliable.

• The 2026-27 one-year planning reference is US$63,279 (INR 60.08 Lakhs), so obtain funding without assuming a first-year salary benchmark.
• The 57-credit curriculum includes 24 thesis credits, so choose a laboratory whose methods can produce demonstrable research outputs.
• The programme is self-funded and assistantships are unguaranteed, so test affordability against the full budget before accepting admission.
• The STEM-coded degree may support 36 months of practical training, so verify the issued I-20 code before treating that window as available.
• For an India return, replace US wage medians with actual local offers for pharmacokinetics, drug-development or regulatory research roles.

US gross pay also differs from take-home pay because federal deductions, benefits and local circumstances change net income. Use a current payroll calculator with the job’s state and benefits before comparing an offer against education cost.

ROI reality: The thesis can build research credibility, but no course salary or offer rate supports a forecast. Enrol only when laboratory fit justifies the self-funded cost without a guaranteed US outcome.

USA Visa for University of Washington MS Pharmacy Students 2027

Admitted international students normally use the F-1 student classification after receiving their Form I-20 from UW. The visa application costs US$185 (INR 17,564), while the separate SEVIS I-901 fee is US$350 (INR 33,229). SEVIS means Student and Exchange Visitor Information System, which records the student’s status before the visa interview.

• Review the official F-1 visa process after UW issues the I-20 and before scheduling the interview.
• OPT means Optional Practical Training and provides up to 12 months, while eligible CIP 51.2003 graduates may seek a 24-month STEM extension.
• H-1B means specialty-occupation work status, whose required wage is the higher of the employer’s actual wage or the local prevailing wage.
• F-2 status covers a spouse or unmarried child under 21, but dependants cannot work and the degree creates no automatic permanent-residence timeline.

Read More: Post-Study Work Options in the USA

Visa reality: CIP 51.2003 supports a possible 36-month OPT window, but the extension needs qualifying employment and an E-Verify employer. Confirm the code printed on UW’s issued I-20.

University of Washington MS Pharmacy Ranking 2027

QS (Quacquarelli Symonds) places the University of Washington at No. 56 for Pharmacy and Pharmacology in its 2026 subject ranking. This is a university-subject result, not a separate score for the MS thesis programme.

Latest published subject evidence: The 2026 edition was released on 25 March 2026 and includes more than 400 institutions. No programme-specific employment conclusion follows from this position.

The ranking supports the broader research environment, while laboratory availability determines this applicant’s actual training opportunity. Compare faculty methods and current lab openings before using the rank as a tie-breaker.

Check Out: University of Washington Rankings

Honest take: No. 56 confirms a recognised pharmacy and pharmacology research footprint, but it does not measure MS outcomes. Laboratory fit remains the stronger course-level decision factor.